The real-time monitoring of patients through medically integrated dispensing (MID) programs can reduce costs of care and remove barriers, said Christie Smith, PharmD, MBA, vice president, pharmacy and payer strategy, Cencora.
Yuqian Liu, PharmD, Magellan Rx Management, explores the current space of cell and gene therapies based on real-world data and potential emerging therapies in the future, while expanding upon long-term efficacy concerns.
/PRNewswire/ Prime Therapeutics LLC/Magellan Rx Management, LLC (Prime/MRx) continues to publish award-winning and industry-leading research on a range of.
The top coverage from this year’s Academy of Managed Care Pharmacy (AMCP) 2023 conference includes interviews on managed care policy, ophthalmic drugs, and formulary management, as well as health plan best practices.
/PRNewswire/ Today, Prime Therapeutics LLC/Magellan Rx Management LLC (Prime/MRx) announces that it has appointed Ken Bodmer as chief financial officer.